Le Lézard4m
Enalare Receives FDA Clearance to Initiate the First Phase 1 Clinical Study of ENA-001 to Be Conducted in the United States
Enalare Therapeutics Inc., a clinical-stage biopharmaceutical company dedicated to developing novel compounds for the treatment of life-threatening critical care conditions and community health ...
The Globe and Mail10m
Q2 Earnings Highs And Lows: Huntington Ingalls (NYSE:HII) Vs The Rest Of The Defense Contractors Stocks
Defense contractors typically require technical expertise and government clearance. Companies in this sector can ...
HOOKIPA Pharma to Present Strong Preclinical HB-700 Dataset
HOOKIPA is very pleased to present a comprehensive preclinical proof-of-concept dataset related to HB-700, for the potential treatment of KRAS mutated cancers. KRAS mutations are most frequently found ...
Altamira Therapeutics Provides Business Update and First Half 2024 Financial Results
Company to host conference call today at 8.30 a.m. ETContinued progress within core activities in RNA delivery, supported by ...